FDA Advisory Group Disagrees With FDA

The FDA asked a panel of scientific experts to review its August report claiming that BPA was safe. Now that panel of science experts challenged the Food and Drug Administration's conclusion noting the FDA should have paid more attention to studies suggesting the contrary, primarily those not supported by the plastics industry.

The FDA report issued in August said that BPA is safe at current levels. Lawmakers and scientists criticized the report because it relied largely on industry-funded studies and contradicted over 100 studies suggesting BPA is harmful to humans. The FDA says it is already moving forward with planned research to address the potential low-dose effects of BPA.